Outcomes of Patients with Acute Type B Aortic Dissection and High-Risk Features

Jonathan R Krebs; Amanda C Filiberto; Brian Fazzone; Christopher R Jacobs; Erik M Anderson; Zain Shahid; Martin Back; Gilbert R Upchurch Jr; Michol Cooper

doi:10.1016/j.avsg.2024.01.012

Outcomes of Patients with Acute Type B Aortic Dissection and High-Risk Features

Ann Vasc Surg. 2024 Apr 2:S0890-5096(24)00128-6. doi: 10.1016/j.avsg.2024.01.012. Online ahead of print.

Authors

Jonathan R Krebs¹, Amanda C Filiberto¹, Brian Fazzone¹, Christopher R Jacobs¹, Erik M Anderson¹, Zain Shahid¹, Martin Back¹, Gilbert R Upchurch Jr¹, Michol Cooper²

Affiliations

¹ Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, FL, USA.
² Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, FL, USA. Electronic address: Michol.cooper@surgery.ufl.edu.

PMID: 38574807
DOI: 10.1016/j.avsg.2024.01.012

Abstract

Background: Recently the SVS and STS published contemporary guidelines clearly defining complicated vs uncomplicated acute type B aortic dissections (TBADs) with an additional high-risk grouping. Few studies have evaluated outcomes associated with "high-risk" TBADs. The objective of this study was to assess differences in demographics, clinical presentation, symptom onset, and outcomes in high-risk patients that underwent either thoracic endovascular aortic repair (TEVAR) or best medical management for acute TBAD compared to those with complicated and uncomplicated acute TBAD.

Methods: Patients admitted with acute TBADs from a single academic medical center from 10/ 2011 to 3/2020 were analyzed. Per STS/SVS 2020 guidelines, high-risk was defined as refractory pain/hypertension, bloody pleural effusion, aortic diameter >4cm, false lumen diameter >22mm, radiographic malperfusion, early readmission, and complicated was defined as ruptured/malperfusion presentation. Uncomplicated patients were those without malperfusion/rupture and without high-risk features. The primary end-point was inpatient mortality. Secondary end-points included complications, re-intervention and survival.

Results: Of 159 patients identified with acute TBAD, 63 (40%) met high-risk criteria. In the high-risk cohort, 38 (60%) underwent TEVAR (HR-TEVAR), with refractory pain as the most common indication, while 25 (40%) were managed medically (HR-Medical). Malperfusion or rupture was present in 63 (40%) patients (C-TBAD), all of whom underwent TEVAR. An additional 33 patients had no high-risk features and were all managed medically (U-TBAD). There were no differences in age, BMI, and race between groups. Among the four groups, there were variable distributions in sex, insurance status, and incidence of several baseline comorbidities including CHF, COPD, and renal dysfunction (p<0.05 for all). C-TBAD had increased length of stay (12, IQR 9-22) compared to HR-TEVAR (11.5, IQR 7-15), HR-Medical (6, IQR 5-8), and U-TBAD (7, IQR 5-10) (p<0.01). C-TBAD had decreased days from admission to repair (0, IQR 0,2) compared to HR-TEVAR (3.5, IQR 1-8) (p<0.01). C-TBAD patients had worse 3-year survival compared to other groups (log-rank p<0.01), although when in-hospital mortality was excluded, survival was similar among groups (p=0.37).Of patients initially managed medically, outpatient TEVAR was performed in 6 (24%) HR-Medical and 4 (12%) uncomplicated patients, with no difference between rate of intervention between groups (p=0.22).

Conclusions: High-risk features, as defined in updated SVS/STS guidelines, are common in patients presenting with acute TBAD. High-risk patients had acceptable outcomes when managed either surgically or medically. High-risk patients that underwent TEVAR had improved perioperative outcomes and mortality compared to those undergoing TEVAR for complicated TBAD, a finding which may help guide preoperative risk stratification and patient counseling.